The Calamos S&P 500® Structured Alt Protection ETF® – February (CPSF) is slated to launch February 3, 2025, with an estimated upside cap range of 7.36%-7.75% over a one-year outcome period.

ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide range of therapeutic areas.

AHMEDABAD, India, Jan. 13, 2025 /PRNewswire/ -- Ishan Technologies, a leading ICT company specializing in system integration, network services, data center, cloud solutions, and cybersecurity, has ...

"The fragmentation of blockchain networks has been a critical issue, and users were compelled to navigate through various DEXs and third-party bridges to perform a single cross-chain transaction," ...

The first half of $11.6M Microelectronics Commons funding for 5G/6G and Electronic Warfare chip technology to be received by January 2025 These prestigious awards further validate Sivers' wireless ...

For many years, ENGWE has been leading the development of fat-tire electric bicycles, providing multi-terrain performance, adventurous aesthetics, and versatility for riders seeking a cooler ride.

Circus SE (XETRA: CA1), a global leader in Physical AI applications, has announced the intended acquisition of FullyAI, one of Europe's leading Agentic AI players. The company has developed ...

Nutanix is a global leader in cloud software, offering organizations a single platform for running applications and managing data, anywhere. With Nutanix, companies can reduce complexity and simplify ...

The conference call replay will be available one hour after the live call has ended and available through January 30, 2025. Webcast and Presentation Slides: To access ...

InflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize ...

CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing regRNA-targeting antisense ...

By working with Fireblocks, IoTeX takes a significant step forward in making native IOTX and IoTeX-based assets accessible to ...